BackEscalon Medical Overview

Escalon Medical Total Revenue

Escalon Medical's total revenue is $8.9B, above the sector sector average of $1.3B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$2.61B
74982.87% YoY

As of Mar 2026

Annual Revenue (TTM)

$8.88B
68466.22% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Escalon Medical (ESMC) FAQ

The latest total revenue for ESMC is $8.9B as of March 2026. That compares with $13M in the prior-year period — up 68466.2% year over year. That is above the sector sector average of $1.3B. Investors often review this figure alongside Escalon Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, ESMC's total revenue moved from $13M to $8.9B — a 68466.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Escalon Medical's operating scale or balance-sheet position.

Against its sector companies, ESMC currently prints $8.9B for total revenue, while the sector average sits near $1.3B. That is roughly 571.9% above the sector mean. Large gaps often invite a closer look at Escalon Medical's growth, margins, and balance sheet.

A total revenue figure of $8.9B for ESMC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting ESMC's total revenue ($8.9B), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.